期刊文献+

终末期肝病模型评分在梗阻性黄疸外科治疗中的意义 被引量:13

Significance of the MELD scoring system in surgical treatment of obstructive jaundice
原文传递
导出
摘要 目的 前瞻性探究终末期肝病模型(MELD)评分在梗阻性黄疸外科治疗中的临床意义.方法 选择我院2009年1月至2013年12月收治的梗阻性黄疸患者112例,分为A组(Ⅰ期行PTCD术,Ⅱ期行开腹手术,n=53)和B组(直接开腹手术,n=59);比较两组术中出血量、手术时间、术后并发症、住院时间、病死率和肝功能指标变化.结果 两组患者开腹术后肝功能指标相同时间点比较,差异均有统计学意义(P<0.05),且A组患者较B组患者肝功能各项指标恢复较快.MELD<10分的患者A组较B组住院时间长;MELD≥10分的A组患者术中出血量、手术时间、术后并发症及住院时间均少于B组(P<0.05);B组MELD≥20分的患者有3例术后死亡.结论 对梗阻性黄疸患者MELD评分大于10分,特别是大于等于20分时,应先行PTCD解除胆道梗阻,待肝功能改善后再行Ⅱ期手术.这样能少出血量、手术时间、术后并发症,缩短住院时间.MELD评分对评估梗阻性黄疸手术风险具有重要的临床意义. Objective To prospectively study the clinical significance of the MELD scoring system in surgical treatment of obstructive jaundice.Methods 112 patients with obstructive jaundice who were admitted into our hospital from January 2009 to December 2013 were divided into two groups:group A (Stage Ⅰ PTCD and stage Ⅱ open operation,n =53) and group B (1 stage open surgery,n =59).The amount of intraoperative bleeding blood loss,operation time,postoperative complications,duration of hospitalization,mortality rate,and the changes in liver function after surgery were compared between the two groups.Results The differences in the liver function index of the two groups on the same postoperative date were significantly different (P 〈 0.05).The liver function of group A recovered faster than group B.Patients in group A with a MELD 〈 10 points stayed in hospital significantly longer when compared with patients in group B.For patients in group A with MELD 〉 10 points,the operation time,bleeding volume,postoperative complications and hospitalization were significantly less than the patients in group B (P 〈 0.05).There were 3 patients (group B) who died with MELD ≥ 20 points after operation.Conclusions In patients with obstructive jaundice with a MELD score greater than 10 points,especially those with a score equal to or greater than 20,PTCD should be performed first to relieve biliary tract obstruction,followed by a stage Ⅱ open surgical operation after the liver function had improved.MELD had important clinical significance in the evaluation of operation risk in patients with obstructive jaundice.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2014年第7期503-506,共4页 Chinese Journal of Hepatobiliary Surgery
基金 湛江市科技计划项目(2013C01032)
关键词 终末期肝病模型 经皮经肝胆道引流 梗阻性黄疸 外科治疗 Obstructive jaundice Surgery treatment
  • 相关文献

参考文献5

二级参考文献40

  • 1黄志强.肝门部胆管癌外科治疗面临的问题与出路[J].中华实验外科杂志,2004,21(7):773-775. 被引量:78
  • 2彭聿平,邱一华.手术应激与免疫抑制[J].生理科学进展,2006,37(1):31-36. 被引量:78
  • 3SD Mansfield,O Barakat,RM Charnley,BC Jaques,CB O'Suilleabhain,PJ Atherton,D Manas.Management of hilar cholangiocarcinoma in the North of England: Pathology, treatment, and outcome[J].World Journal of Gastroenterology,2005,11(48):7625-7630. 被引量:37
  • 4Chandra Shekhar Bhati,Chandrashekhar Kubal,Pankaj Kumar Sihag,Ankur Atal Gupta,Raj Kamal Jenav,Nicholas G Inston,Jagdish M Mehta.Effect of preoperative biliary drainage on outcome of classical pancreaticoduodenectomy[J].World Journal of Gastroenterology,2007,13(8):1240-1242. 被引量:12
  • 5黎介寿 吴孟超.普通外科手术学(第2版)[M].北京:人民军医出版社,2005.684.
  • 6王卉放 许化溪 严俊.胆红素抗氧化作用与免疫调节关系的研究[J].中国应用生理学杂志,1997,13(1):39-39.
  • 7Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973, 60:646-649.
  • 8Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child- Turcotte criteria in medically treated cirrhosis. Hepatology,1984, 4: 430-435.
  • 9Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology, 1987, 7: 660-664.
  • 10Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.

共引文献149

同被引文献120

  • 1李儒贵,占国清,谭华炳,李芳,李刚,张薇薇.肝衰竭合并细菌和真菌感染的特点及对预后的影响[J].湖北医药学院学报,2013,32(4):321-324. 被引量:2
  • 2朱峰,秦锡虎,黄伯华,杨振林,张浩,郑树森.肝硬化合并胆道疾病术中大出血的防治(附五例临床分析)[J].中华肝胆外科杂志,2005,11(2):98-100. 被引量:16
  • 3刘青,刘铮,王泰龄,张立丽.应用MELD系统预测慢性重型肝炎的预后及其治疗效果[J].中华医学杂志,2005,85(25):1773-1777. 被引量:24
  • 4Schattenberg JM,Galle PR,Schuchmann M.apoptosis in liver disease[J].Liver lnt,2006,26(8):904-911.
  • 5Bergheim I,Guo L,Davis MA,et al.Critical role ofplasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis[J].J Pharmacol Exp Ther,2006,316(2):592- 600.
  • 6Hoffmann K,Hinz U,Hillebrand N,et al.The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases[J].Langenbecks Arch Surg,2014,399(8):1001-1009.
  • 7Hoyer DP,Sotiropoulos GC,Saner FH,et al.MELD at POD 1 as a predictor of outcome in liver allografts with peak AST>5000U/l[J].Transpl Int,2014,27(12):1285-1293.
  • 8Hu Z,Li Z,Xiang J,et al.Intent-to-treat analysis of liver transplant for hepatocellular carcinoma in the MELD era:impact of hepatitis C and advanced status[J].Dig Dis Sci,2014,59(12):3062-3072.
  • 9Kaiser T,Zeuzem S,Lichtinghagen R,et al.Multi-center proficiency tests for Lab-MELD score diagnostics to improve the quality and safety for patients awaiting liver transplantation[J].Clin Chem Lab Med,2014,52(12):e287-289.
  • 10Costabeber AM,Liono LC,Marroni C,et al.D-MELD does not predict post-liver transplantation survival:a single-center experience from Brazil[J].Ann Hepatol,2014,13(6):781-787.

引证文献13

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部